- Home
- FEAM vs IMMX Comparison
FEAM vs IMMX Comparison
Compare FEAM & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FEAM
- IMMX
- Stock Information
- Founded
- FEAM 2016
- IMMX 2014
- Country
- FEAM United States
- IMMX United States
- Employees
- FEAM N/A
- IMMX N/A
- Industry
- FEAM Major Chemicals
- IMMX Medicinal Chemicals and Botanical Products
- Sector
- FEAM Industrials
- IMMX Health Care
- Exchange
- FEAM Nasdaq
- IMMX Nasdaq
- Market Cap
- FEAM 46.9M
- IMMX 51.1M
- IPO Year
- FEAM N/A
- IMMX 2021
- Fundamental
- Price
- FEAM $0.69
- IMMX $1.66
- Analyst Decision
- FEAM Buy
- IMMX Strong Buy
- Analyst Count
- FEAM 4
- IMMX 1
- Target Price
- FEAM $4.19
- IMMX $7.00
- AVG Volume (30 Days)
- FEAM 159.3K
- IMMX 125.2K
- Earning Date
- FEAM 11-07-2024
- IMMX 11-11-2024
- Dividend Yield
- FEAM N/A
- IMMX N/A
- EPS Growth
- FEAM N/A
- IMMX N/A
- EPS
- FEAM N/A
- IMMX N/A
- Revenue
- FEAM N/A
- IMMX N/A
- Revenue This Year
- FEAM N/A
- IMMX N/A
- Revenue Next Year
- FEAM $1,117.19
- IMMX $200.00
- P/E Ratio
- FEAM N/A
- IMMX N/A
- Revenue Growth
- FEAM N/A
- IMMX N/A
- 52 Week Low
- FEAM $0.40
- IMMX $1.26
- 52 Week High
- FEAM $3.35
- IMMX $7.75
- Technical
- Relative Strength Index (RSI)
- FEAM 58.83
- IMMX 45.76
- Support Level
- FEAM $0.45
- IMMX $1.43
- Resistance Level
- FEAM $0.50
- IMMX $1.94
- Average True Range (ATR)
- FEAM 0.08
- IMMX 0.13
- MACD
- FEAM 0.04
- IMMX -0.01
- Stochastic Oscillator
- FEAM 72.73
- IMMX 57.97
About FEAM 5E Advanced Materials Inc.
5E Advanced Materials Inc is engaged boron specialty advanced materials and lithium with a focus on enabling decarbonization, including electric transportation, clean energy, and food security.
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.